Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlencowe Resources Regulatory News (BRES)

Share Price Information for Blencowe Resources (BRES)

Share Price is delayed by 15 minutes
Get Live Data
7.25    -0.05 (-0.68%)
Bid:
7.10
Ask:
7.40
Spread: 0.30 (4.225%)
Market Cap: £35.70m
BRES Live PriceLast checked at - London Stock Exchange

Intraday Blencowe Resources Share Chart

Offtake Agreement Signed

1 Aug 2025 07:00

RNS Number : 5084T
Blencowe Resources PLC
01 August 2025
 

Date: 01 August 2025

Blencowe Resources

("Blencowe" or the "Company"),

 

Offtake Agreement Signed with Established UK Graphene Manufacturer for Orom-Cross Graphite

Deal unlocks higher-value western sales channel and potential UK Government funding support

 

Blencowe Resources Plc ("Blencowe") is pleased to announce the signing of an additional Non-binding Agreement ("Agreement") for offtake of natural fine flake concentrate from its Orom-Cross Graphite Project with Perpetuus Advanced Materials Limited. ("PAM"). PAM is a UK based advanced materials innovator with more than a decade of expertise in plasma-treated graphene production.

The Agreement covers 19,000 tonnes of +97% TGC fine flake graphite over an initial five-year term, representing a significant portion of Orom-Cross's planned Phase 1 output of 10,000tpa, with volumes likely to rise further as PAM leads the way globally in manufacturing plasma-treated, surface engineered graphenes and sub-micron particles for commercial uses.

PAM's proprietary requirement for high quality graphite validates Orom-Cross's product and provides Blencowe with a valuable additional western offtake partner. Sales into UK markets also create a pathway to access specialist UK Government critical mineral funding for initial project implementation, which requires domestic offtake into export-driven supply chains.

 

Highlights:

· 19,000 tonnes of +97% fine flake graphite concentrate to be supplied over initial 5-year term, ramping up thereafter.

· Products tested and validated through PAM's proprietary systems.

· Agreement supports Blencowe's strategy to prioritise high-value western offtakers.

· Fine flake sales to western markets currently attract in excess of US$1,200 per tonne which is significantly higher than Asian prices for similar products.

· Builds case for UK Government funding support via existing critical mineral schemes.

· Agreement follows a recent, successful UK, US, and EU marketing roadshow with further offtake discussions ongoing.

 

Strategic Implications

This Agreement represents a major commercial milestone for Blencowe, adding another high-value, long-term offtake partner from a western market and further validating Orom-Cross's premium product quality.

PAM's proprietary dry environmentally friendly, plasma process converts fine flake graphite to industrial scale surface engineered graphenes, currently utilised by manufacturers requiring lighter, stronger and more energy‑efficient products.

Importantly, the Agreement covers a significant component of Blencowe's proposed steady state production of fine flake products from both Phase 1 and Phase 2 production, and it continues the commitment of the Company in diversifying offtakes away from lower-margin bulk markets into higher value applications and cleaner processing technologies. This includes graphene-enabled solutions in automotive, defence, and electronics which are all areas where pricing and margins are typically stronger.

Beyond PAM, Blencowe has engaged in advanced discussions with other OEMs and leading downstream processors in the UK, Europe, and the United States. These firms are conducting quality testing of Orom-Cross material following the Company's recent marketing roadshow. Early feedback is encouraging.

As these discussions progress, Blencowe remains focused on building a robust and diversified offtake book across multiple geographies and end-use sectors. This will support a strong commercial foundation for full Phase 2 production at 50,000tpa - positioning Orom-Cross as a leading supplier into both traditional and emerging graphite markets.

 

UK Government Support Pathway

UK Government funding schemes linked to domestic critical mineral supply chains require offtake into UK companies that export finished goods. This Agreement with PAM meets that criterion, allowing Blencowe to progress its funding application for P1 production, and potentially reducing future financing risk.

 

John Buckland, Chief Executive of Perpetuus Advanced Materials, commented:

"Blencowe's premium Orom‑Cross graphite provides a secure, high purity feedstock required to scale our plasma surface engineered graphene manufacturing programme and the commercial launch of our current performance tyre, fertiliser and battery storage products."

 

"This supply of feedstock will also fast track our next wave of aluminium, polymer and petrochemical graphene enhanced products and enable future commercial development of our extensive panoply of 'pre-production' prototypes."

 

Blencowe Executive Chairman Cameron Pearce commented:

"This offtake Agreement is one of the most significant to date for Orom-Cross in that it provides substantial sales of fine flake concentrate into a leading western buyer. Western markets are currently paying considerably more per tonne for fine flake concentrate than Asian markets so the more western contracts we can bring in the better." 

"We understand that PAM intends to leverage its ability to produce industrial quantities of high quality surface engineered graphenes to innovate and develop graphene enabled products. We hope to be providing PAM with considerable quantities of product over a long period into the future as both companies expand our respective operations."

"Once again the high quality of Orom-Cross graphite is clearly differentiating our product from our peers and I cannot stress how important this is in building a successful commercial model. Added to which this particular sale channel opens the door for Blencowe to pursue niche UK Government funding support, which could provide yet another unique value-add proposition for our Company."

 

Blencowe CEO, Mike Ralston, talks about this offtake agreement and other Company matters in the following two interviews:

https://media.focusir.com/BlencoweResourcesAnnouncesOfftakePartnerInTheUK

https://www.voxmarkets.co.uk/articles/q-a-with-blencowe-resources-ceo-mike-ralston-00ae062

 

 

For further information please contact:

 

Blencowe Resources Plc

Sam Quinn

 

www.blencoweresourcesplc.com

Tel: +44 (0)1624 681 250

info@blencoweresourcesplc.com

 

Investor Relations

Sasha Sethi

Tel: +44 (0) 7891 677 441

Sasha.sethi@blencoweresourcesplc.com 

Tavira Securities 

Jonathan Evans

Tel: +44 (0)20 3192 1733

jonathan.evans@tavira.group

 

Twitter https://twitter.com/BlencoweRes

LinkedIn https://www.linkedin.com/company/72382491/admin/

 

 

 

 

 

Background

 

Orom-Cross Graphite Project

Orom-Cross is a potential world class graphite project both by size and end-product quality, with a high component of more valuable larger flakes within the deposit.

A 21-year Mining Licence for the project was issued by the Ugandan Government in 2019 following extensive historical work on the deposit and Blencowe is now completing the Definitive Feasibility Study phase as it drives towards first production.

Orom-Cross presents as a large, shallow open-pitable deposit, with a maiden JORC Indicated & Inferred Mineral Resource deposit of 24.5Mt @ 6.0% Total Graphite Content. Development of the resource is expected to benefit from a low strip ratio and free dig operations, thereby ensuring lower operating and capital costs.

 

Perpetuus Advance Materials Limited.

Perpetuus Advanced Materials is a UK company with over ten years' experience in the development of plasma-treated, surface engineered graphenes, and sub-micron particles for commercial use. It is considered a global leader in its fields of expertise.

Perpetuus has developed the first in its range of proprietary nano engineered graphene-enhanced masterbatch compounds, formulated specifically for the field of commercial, passenger and industrial tyre manufacturing sectors. The initial offering will be broadened to include other polymer/elastomer masterbatches suitable for industries such as hoses, seals, gaskets, V-belts, and conveyor belts.

Using its environmentally friendly, plasma treatment process, Perpetuus graphenes are integrated into the masterbatch. The resultant masterbatch is now available in industrial quantities, allowing tyre manufacturers to integrate this breakthrough material into their existing production processes.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRPKDBNKBKBFON
Date   Source Headline
13th Jan 20227:00 amRNSAppointment of Battery Limits
17th Dec 20211:04 pmRNSIssue of Options
16th Dec 20217:00 amRNSGraphite Sales and Marketing Expert Appointed
10th Dec 20213:35 pmRNSPublication of a Prospectus
8th Dec 202110:11 amRNSResult of General Meeting
8th Dec 20218:28 amRNSWebinar Call
15th Nov 202111:56 amRNSAMENDED Notice of General Meeting
15th Nov 202111:37 amRNSNotice of GM
12th Nov 20218:33 amRNSOver-Subscribed £2m Capital Raise
4th Oct 20217:00 amRNSCorporate Presentation
29th Sep 20217:00 amRNSOrom Cross PEA
20th Sep 20217:00 amRNSOrom Cross Update
17th Sep 20219:19 amRNSTR-1: Standard form notification of major holdings
16th Aug 20217:00 amRNSSecond Drilling Program at Orom-Cross Project
20th Jul 20212:01 pmRNSInvitation to Webinar
14th Jul 20217:00 amRNSIssue of Equity
13th Jul 20217:34 amRNSResults of Metallurgical Test Work
5th Jul 20217:00 amRNSDrill Program Ahead of Schedule
24th Jun 20214:00 pmRNSTR-1: Standard form notification of major holdings
2nd Jun 20219:54 amRNSHalf-year Report
1st Jun 20217:00 amRNSTR-1: Standard form notification of major holdings
24th May 20217:00 amRNSMetallurgical Test Work
19th May 202111:34 amRNSUpdated Corporate Presentation
14th May 202112:00 pmRNSTransaction in Shares
4th May 20217:00 amRNSStage Two Drilling Program Commences
29th Apr 20212:12 pmRNSDirector/PDMR Shareholding
26th Apr 20211:26 pmRNSHolding(s) in Company
13th Apr 20217:30 amRNSInvestor Webinar
13th Apr 20217:00 amRNSMaiden JORC Mineral Resource
7th Apr 20212:30 pmRNSWarrant Exercise
31st Mar 202110:08 amRNSResult of AGM
24th Mar 202111:30 amRNSWarrant Exercise
8th Mar 20214:30 pmRNSNotice of AGM
1st Mar 20217:00 amRNSDrilling Results
12th Feb 20217:00 amRNSTR-1: Standard form notification of major holdings
8th Feb 20212:12 pmRNSWarrant Exercise
8th Feb 20217:07 amRNSDrilling Results at Camp Lode
26th Jan 20217:00 amRNSAnnual Financial Report
22nd Jan 20211:07 pmRNSInvestor Conference Call
18th Jan 20217:00 amRNSPlacing to Raise £500,000
16th Dec 20207:00 amRNSPlacing to Raise £300,000
9th Dec 20209:52 amRNSTR-1: Standard form notification of major holdings
1st Dec 202011:01 amRNSBlock Listing Application Update
27th Nov 202012:11 pmRNSBlock Listing Application Update
26th Nov 20207:16 amRNSJORC Resource Update
25th Nov 20201:59 pmRNSBlock Listing Application & Issue of Equity
23rd Nov 20207:00 amRNSDirector Warrant Exercise and Purchase of Shares
5th Nov 20207:00 amRNSPublication of New Research Note
14th Oct 20202:07 pmRNSHolding(s) in Company
14th Oct 20207:21 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.